Serum gold. II. Levels in rheumatoid arthritis.
作者信息
Rubinstein H M, Dietz A A
出版信息
Ann Rheum Dis. 1973 Mar;32(2):128-32. doi: 10.1136/ard.32.2.128.
Abstract
摘要
相似文献
1
Serum gold. II. Levels in rheumatoid arthritis.
Ann Rheum Dis. 1973 Mar;32(2):128-32. doi: 10.1136/ard.32.2.128.
2
[Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
Med Clin (Barc). 1985 Jun 8;85(2):73-9.
3
Comparative toxicity of gold preparations in treatment of rheumatoid arthritis.
Ann Rheum Dis. 1976 Apr;35(2):171-3. doi: 10.1136/ard.35.2.171.
4
Serum gold. I. Estimation by atomic absorption spectroscopy.
Ann Rheum Dis. 1973 Mar;32(2):124-7. doi: 10.1136/ard.32.2.124.
5
Gold levels in serum during the treatment of rheumatoid arthritis with gold sodium thiomalate.
Aust N Z J Med. 1973 Oct;3(5):461-6. doi: 10.1111/j.1445-5994.1973.tb03123.x.
6
Quantitation of gold lymphocyte binding during chrysotherapy.
J Rheumatol. 1979 May-Jun;6(3):270-6.
7
[Distribution of gold from aurothiomalate and gold trielthylphosphine in whole blood, lymphocytes and lymphocyte chromatin of patients with chronic polyarthritis].
Wien Klin Wochenschr Suppl. 1984;156:53-5.
8
Monitoring serum gold values to improve chrysotherapy in rheumatoid arthritis.
Ann Rheum Dis. 1973 Mar;32(2):133-9. doi: 10.1136/ard.32.2.133.
9
Lack of correlation between blood gold concentrations and clinical response in patients with definite or classic rheumatoid arthritis receiving auranofin or gold sodium thiomalate.
Arthritis Rheum. 1985 Nov;28(11):1211-8. doi: 10.1002/art.1780281104.
10
Idiosyncratic reactions to gold salt preparations.
Arthritis Rheum. 1978 Mar;21(2):281. doi: 10.1002/art.1780210225.
引用本文的文献
1
In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microflora.
RMD Open. 2021 Sep;7(3). doi: 10.1136/rmdopen-2021-001737.
2
Gold in erythrocytes, whole blood, and plasma during long-term chrysotherapy.
Ann Rheum Dis. 1980 Dec;39(6):576-9. doi: 10.1136/ard.39.6.576.
3
Gold binding to blood cells and serum proteins during chrysotherapy.
Ann Rheum Dis. 1980 Feb;39(1):31-6. doi: 10.1136/ard.39.1.31.
4
Remission-inducing drugs in rheumatoid arthritis.
Can Med Assoc J. 1980 Feb 23;122(4):405-15.
5
Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.
Ann Rheum Dis. 1984 Oct;43(5):698-702. doi: 10.1136/ard.43.5.698.
6
Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).
Clin Rheumatol. 1984 Mar;3 Suppl 1:17-24. doi: 10.1007/BF03342618.
7
Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
Drugs. 1984 May;27(5):378-424. doi: 10.2165/00003495-198427050-00002.
8
A comparison of the effects of two gold-containing therapeutic agents on articular chondrocyte growth in vitro.
Rheumatol Int. 1983;3(2):49-56. doi: 10.1007/BF00541144.
9
Serum gold concentrations during treatment with auranofin.
Clin Rheumatol. 1987 Mar;6(1):50-4. doi: 10.1007/BF02201000.
10
Gold-induced aplastic anemia.
Clin Rheumatol. 1987 Dec;6(4):600-5. doi: 10.1007/BF02330601.
本文引用的文献
1
Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.
Arthritis Rheum. 1968 Apr;11(2):170-7. doi: 10.1002/art.1780110207.
2
Gold nephropathy. A clinical and pathologic study.
Arthritis Rheum. 1970 Nov-Dec;13(6):812-25. doi: 10.1002/art.1780130611.
3
Plasma levels and urinary excretion of gold during routine treatment of rheumatoid arthritis.
Ann Rheum Dis. 1970 May;29(3):232-5. doi: 10.1136/ard.29.3.232.
4
Serum gold. I. Estimation by atomic absorption spectroscopy.
Ann Rheum Dis. 1973 Mar;32(2):124-7. doi: 10.1136/ard.32.2.124.
Zotero 插件